RSPO1 and colorectal carcinoma: The mutated organoids were also provided with a culture environment containing inhibitors of Wnt, R-spondin, epidermal growth factor (EGF), and bone morphogenetic protein/transforming growth factor-β, which are essential for colorectal cancer (CRC) organoids of patient origin.